Key stats
About Huaan Guozheng Biomedical ETF
Home page
Inception date
Jun 29, 2023
Structure
Open-Ended Fund
Replication method
Physical
Primary advisor
HuaAn Fund Management Co., Ltd.
ISIN
CNE1000063X0
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks97.00%
Health Technology89.31%
Process Industries6.66%
Commercial Services1.03%
Bonds, Cash & Other3.00%
Cash3.00%
Stock breakdown by region
Asia100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
159508 invests in stocks. The fund's major sectors are Health Technology, with 89.31% stocks, and Process Industries, with 6.66% of the basket. The assets are mostly located in the Asia region.
159508 top holdings are WuXi AppTec Co., Ltd. Class A and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Class A, occupying 9.94% and 6.23% of the portfolio correspondingly.
No, 159508 doesn't pay dividends to its holders.
159508 shares are issued by Guotai Junan Securities Co., Ltd. under the brand HuaAn. The ETF was launched on Jun 29, 2023, and its management style is Passive.
159508 expense ratio is 0.60% meaning you'd have to pay 0.60% of your investment to help manage the fund.
159508 follows the National Securities Biomedical Index - CNY - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
159508 invests in stocks.